Pfizer Inc. v. Novo Nordisk A/S > Summary
Court Case Number IPR2020-01252
Filing Date Jul 22, 2020
Institution Decision Date Dec 4, 2020
Decision Date Jun 21, 2021
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesErica A. Franklin, John G. New, Susan L. C. Mitchell
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Patent Owner
Petitioner Attorneys
3Pfizer
Attorney Name: Jovial Wong
Winston & Strawn
Pfizer
Attorney Name: Charles B. Klein
Winston & Strawn
Pfizer
Attorney Name: Sharon Lin
Winston & Strawn
Patent Owner Attorneys
3Novo Nordisk
Attorney Name: Jeffrey J. Oelke
Fenwick & West LLP
Novo Nordisk
Attorney Name: Ryan Johnson
Fenwick & West LLP
Novo Nordisk
Attorney Name: Laura Moran
Fenwick & West LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
08114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | Feb 14, 2012 |